Detalhe da pesquisa
1.
Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation.
Oncoimmunology
; 11(1): 2117321, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117525
2.
Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer.
Immunol Med
; 44(3): 159-174, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33164702
3.
Developing an Arrayed CRISPR-Cas9 Co-Culture Screen for Immuno-Oncology Target ID.
SLAS Discov
; 25(6): 581-590, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32375580
4.
A cell-engineered system to assess tumor cell sensitivity to CD8+ T cell-mediated cytotoxicity.
Oncoimmunology
; 8(8): 1599635, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413906
5.
Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.
PLoS One
; 12(2): e0170197, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152014
6.
Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis.
PLoS One
; 10(1): e0115546, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629611
7.
Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
J Vis Exp
; (64): e3875, 2012 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-22733203
8.
Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.
PLoS One
; 6(11): e27729, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22132131